Date published: 2026-4-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Tetanus Toxin, C-Fragment

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
TTC
Application:
Tetanus Toxin, C-Fragment is a C-terminal binding portion of the heavy chain of tetanus toxin
Purity:
Single major band by SDS-PAGE
Molecular Weight:
47000
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Tetanus Toxin, C-Fragment refers to the C-terminal binding component of the heavy chain derived from tetanus toxin, an infectious substance produced by the Gram-positive bacterium Clostridium tetani, found in soil and the gastrointestinal tracts of animals. Tetanus Toxin is a 150.7 kDa protein consisting of a 52.4 kDa light chain and a 98.3 kDa heavy chain connected by a disulfide bond. The heavy chain comprises fragments B and C, with fragment C weighing 51.6 kDa and positioned at the C-terminus, responsible for neuronal cell binding. The non-toxic nature, immunological attributes, and neuronal binding properties of the tetanus toxin fragment C (TTFC) have rapidly brought it into the spotlight. Thus, It serves as useful for binding studies. The tetanus toxin fragment C (TTFC) has garnered considerable attention due to its neurological properties in vitro. As a derivative of the tetanus toxin, it retains its immunogenic properties without toxicity. Moreover, TTFC has undergone extensive characterization, and its complete structure is known. Tetanus Toxin operates by inhibiting neurotransmitter release, leading to spastic paralysis through a four-step process. Firstly, Tetanus Toxin binds to specific receptors, predominantly composed of lipids and gangliosides, located at the neuromuscular junction. Additionally, Tetanus Toxin engages another receptor involved in its internalization, thereby establishing a strong affinity between Tetanus Toxin and nerve cells. Subsequently, Tetanus Toxin undergoes axonal retrograde transport to reach the cell body. Finally, Tetanus Toxin cleaves the VAMP/synaptobrevin, a neuronal substrate, via proteolysis, resulting in the inhibition of neurotransmitter release.


Tetanus Toxin, C-Fragment References

  1. Identification of novel small molecule ligands that bind to tetanus toxin.  |  Lightstone, FC., et al. 2000. Chem Res Toxicol. 13: 356-62. PMID: 10813652
  2. Enhancement of diphtheria toxin potency by replacement of the receptor binding domain with tetanus toxin C-fragment: a potential vector for delivering heterologous proteins to neurons.  |  Francis, JW., et al. 2000. J Neurochem. 74: 2528-36. PMID: 10820215
  3. Identification of novel small molecules that bind to two different sites on the surface of tetanus toxin C fragment.  |  Cosman, M., et al. 2002. Chem Res Toxicol. 15: 1218-28. PMID: 12387617
  4. A genetic fusion construct between the tetanus toxin C fragment and the lysosomal acid hydrolase beta-glucuronidase expresses a bifunctional protein with enhanced secretion and neuronal uptake.  |  Jiang, K., et al. 2005. J Neurochem. 93: 1334-44. PMID: 15934952
  5. Tetanus toxin C fragment-conjugated nanoparticles for targeted drug delivery to neurons.  |  Townsend, SA., et al. 2007. Biomaterials. 28: 5176-84. PMID: 17854886
  6. Cathepsin E regulates the presentation of tetanus toxin C-fragment in PMA activated primary human B cells.  |  Burster, T., et al. 2008. Biochem Biophys Res Commun. 377: 1299-303. PMID: 18996084
  7. Fluorescence emission and polarization for analyzing binding of ruthenium metalloglycocluster to lectin and tetanus toxin C-fragment.  |  Okada, T., et al. 2009. Bioconjug Chem. 20: 1296-8. PMID: 19537755
  8. Fluorescence emission and polarization analyses for evaluating binding of ruthenium metalloglycoclusters to lectins and tetanus toxin C-fragment.  |  Okada, T. and Minoura, N. 2011. J Biomed Opt. 16: 037001. PMID: 21456874
  9. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.  |  Amuguni, JH., et al. 2011. Vaccine. 29: 4778-84. PMID: 21565244
  10. Enhanced CNS uptake of systemically administered proteins through conjugation with tetanus C-fragment.  |  Fishman, PS., et al. 1990. J Neurol Sci. 98: 311-25. PMID: 2243237
  11. Transsynaptic retrograde transport of fragment C of tetanus toxin demonstrated by immunohistochemical localization.  |  Evinger, C. and Erichsen, JT. 1986. Brain Res. 380: 383-8. PMID: 2428427
  12. The restorative effect of intramuscular injection of tetanus toxin C-fragment in hemiparkinsonian rats.  |  Sánchez-González, A., et al. 2014. Neurosci Res. 84: 1-9. PMID: 24815514
  13. Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments.  |  Helting, TB. and Zwisler, O. 1977. J Biol Chem. 252: 187-93. PMID: 401808
  14. Antigenic substructure of tetanus neurotoxin.  |  Matsuda, M. and Yoneda, M. 1977. Biochem Biophys Res Commun. 77: 268-74. PMID: 407907
  15. [Molecular mechanism of action of tetanus toxin and botulinum neurotoxins].  |  Poulain, B. 1994. Pathol Biol (Paris). 42: 173-82. PMID: 7916455

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Tetanus Toxin, C-Fragment, 10 µg

sc-222346
10 µg
$781.00